A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor effects by combining with a vaccinia viral vaccine

Hee Dong Han, Chung Kil Song, Yong Sung Park, Kyung Hee Noh, Jin Hee Kim, Taewon Hwang, Tae Woo Kim, Byung Cheol Shin

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

Cancer treatment combining chemotherapy and immunotherapy has been vigorously exploited to further improve cancer therapeutic efficacy. This study investigated a new chemoimmunotherapy approach utilizing hydrogel as a local anti-cancer drug delivery system. Chitosan hydrogel containing doxorubicin (CH-DOX) and vaccinia virus vaccine expressing Sig/E7/LAMP-1 (Vac-Sig/E7/LAMP-1) were used as chemoimmunotherapeutic agents. It was found that intratumoral injection of CH-DOX effectively inhibited tumor growth itself and, in addition, exhibited a synergistic antitumor effect in combination with a vaccinia virus-based vaccine. This combination did not decrease but rather increased the number of tumor-specific CD8+ T cells primed by vaccinia virus-mediated vaccination; the resulting antitumor effects were further improved up to 60 days as compared with monotherapy after tumor challenge, and the survival of tumor-bearing mice was dramatically prolonged. This study is a pioneer report that demonstrates the use of a biodegradable hydrogel system as an anti-cancer drug delivery system for successful chemoimmunotherapy. It is hoped that, this study can provide a foundation for a rational approach to improve antitumor efficacy of chemoimmunotherapy.

Original languageEnglish
Pages (from-to)27-34
Number of pages8
JournalInternational Journal of Pharmaceutics
Volume350
Issue number1-2
DOIs
Publication statusPublished - 2008 Feb 28

Fingerprint

Viral Vaccines
Vaccinia
Hydrogel
Chitosan
Drug Delivery Systems
Vaccinia virus
Neoplasms
Doxorubicin
Vaccines
Immunotherapy
Vaccination
T-Lymphocytes
Drug Therapy
Injections

Keywords

  • Chemoimmunotherapy
  • Doxorubicin
  • Hydrogel
  • Vaccinia vaccine

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor effects by combining with a vaccinia viral vaccine. / Han, Hee Dong; Song, Chung Kil; Park, Yong Sung; Noh, Kyung Hee; Kim, Jin Hee; Hwang, Taewon; Kim, Tae Woo; Shin, Byung Cheol.

In: International Journal of Pharmaceutics, Vol. 350, No. 1-2, 28.02.2008, p. 27-34.

Research output: Contribution to journalArticle

Han, Hee Dong ; Song, Chung Kil ; Park, Yong Sung ; Noh, Kyung Hee ; Kim, Jin Hee ; Hwang, Taewon ; Kim, Tae Woo ; Shin, Byung Cheol. / A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor effects by combining with a vaccinia viral vaccine. In: International Journal of Pharmaceutics. 2008 ; Vol. 350, No. 1-2. pp. 27-34.
@article{cfb5fa1724704493a663d9c25d2241ca,
title = "A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor effects by combining with a vaccinia viral vaccine",
abstract = "Cancer treatment combining chemotherapy and immunotherapy has been vigorously exploited to further improve cancer therapeutic efficacy. This study investigated a new chemoimmunotherapy approach utilizing hydrogel as a local anti-cancer drug delivery system. Chitosan hydrogel containing doxorubicin (CH-DOX) and vaccinia virus vaccine expressing Sig/E7/LAMP-1 (Vac-Sig/E7/LAMP-1) were used as chemoimmunotherapeutic agents. It was found that intratumoral injection of CH-DOX effectively inhibited tumor growth itself and, in addition, exhibited a synergistic antitumor effect in combination with a vaccinia virus-based vaccine. This combination did not decrease but rather increased the number of tumor-specific CD8+ T cells primed by vaccinia virus-mediated vaccination; the resulting antitumor effects were further improved up to 60 days as compared with monotherapy after tumor challenge, and the survival of tumor-bearing mice was dramatically prolonged. This study is a pioneer report that demonstrates the use of a biodegradable hydrogel system as an anti-cancer drug delivery system for successful chemoimmunotherapy. It is hoped that, this study can provide a foundation for a rational approach to improve antitumor efficacy of chemoimmunotherapy.",
keywords = "Chemoimmunotherapy, Doxorubicin, Hydrogel, Vaccinia vaccine",
author = "Han, {Hee Dong} and Song, {Chung Kil} and Park, {Yong Sung} and Noh, {Kyung Hee} and Kim, {Jin Hee} and Taewon Hwang and Kim, {Tae Woo} and Shin, {Byung Cheol}",
year = "2008",
month = "2",
day = "28",
doi = "10.1016/j.ijpharm.2007.08.014",
language = "English",
volume = "350",
pages = "27--34",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor effects by combining with a vaccinia viral vaccine

AU - Han, Hee Dong

AU - Song, Chung Kil

AU - Park, Yong Sung

AU - Noh, Kyung Hee

AU - Kim, Jin Hee

AU - Hwang, Taewon

AU - Kim, Tae Woo

AU - Shin, Byung Cheol

PY - 2008/2/28

Y1 - 2008/2/28

N2 - Cancer treatment combining chemotherapy and immunotherapy has been vigorously exploited to further improve cancer therapeutic efficacy. This study investigated a new chemoimmunotherapy approach utilizing hydrogel as a local anti-cancer drug delivery system. Chitosan hydrogel containing doxorubicin (CH-DOX) and vaccinia virus vaccine expressing Sig/E7/LAMP-1 (Vac-Sig/E7/LAMP-1) were used as chemoimmunotherapeutic agents. It was found that intratumoral injection of CH-DOX effectively inhibited tumor growth itself and, in addition, exhibited a synergistic antitumor effect in combination with a vaccinia virus-based vaccine. This combination did not decrease but rather increased the number of tumor-specific CD8+ T cells primed by vaccinia virus-mediated vaccination; the resulting antitumor effects were further improved up to 60 days as compared with monotherapy after tumor challenge, and the survival of tumor-bearing mice was dramatically prolonged. This study is a pioneer report that demonstrates the use of a biodegradable hydrogel system as an anti-cancer drug delivery system for successful chemoimmunotherapy. It is hoped that, this study can provide a foundation for a rational approach to improve antitumor efficacy of chemoimmunotherapy.

AB - Cancer treatment combining chemotherapy and immunotherapy has been vigorously exploited to further improve cancer therapeutic efficacy. This study investigated a new chemoimmunotherapy approach utilizing hydrogel as a local anti-cancer drug delivery system. Chitosan hydrogel containing doxorubicin (CH-DOX) and vaccinia virus vaccine expressing Sig/E7/LAMP-1 (Vac-Sig/E7/LAMP-1) were used as chemoimmunotherapeutic agents. It was found that intratumoral injection of CH-DOX effectively inhibited tumor growth itself and, in addition, exhibited a synergistic antitumor effect in combination with a vaccinia virus-based vaccine. This combination did not decrease but rather increased the number of tumor-specific CD8+ T cells primed by vaccinia virus-mediated vaccination; the resulting antitumor effects were further improved up to 60 days as compared with monotherapy after tumor challenge, and the survival of tumor-bearing mice was dramatically prolonged. This study is a pioneer report that demonstrates the use of a biodegradable hydrogel system as an anti-cancer drug delivery system for successful chemoimmunotherapy. It is hoped that, this study can provide a foundation for a rational approach to improve antitumor efficacy of chemoimmunotherapy.

KW - Chemoimmunotherapy

KW - Doxorubicin

KW - Hydrogel

KW - Vaccinia vaccine

UR - http://www.scopus.com/inward/record.url?scp=38549097080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38549097080&partnerID=8YFLogxK

U2 - 10.1016/j.ijpharm.2007.08.014

DO - 10.1016/j.ijpharm.2007.08.014

M3 - Article

VL - 350

SP - 27

EP - 34

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1-2

ER -